首页 › 基金 › Parkman Healthcare Partners LLC › RMD
Parkman Healthcare Partners LLC 对 RMD 的持仓历史
RESMED INC · 医疗保健
Parkman Healthcare Partners LLC 在 Q2 2026 的 13F 申报中披露持有 RMD(RESMED INC)32,983 股,市值约 US$6.4M,约占其申报组合的 0.66%,在其申报持仓中市值排名第 50 位。 Parkman Healthcare Partners LLC 最近 6 个申报季度中有 2 个季度披露了 RMD 持仓,最早可追溯至 Q1 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Parkman Healthcare Partners LLC 对 RMD 的持仓演变
Parkman Healthcare Partners LLC 于 Q1 2025 首次披露 RMD 持仓:22,622 股(约 US$5.1M)。 该持仓在 Q2 2026 达到峰值 32,983 股,市值约 US$6.4M。 在 2 次申报中,Parkman Healthcare Partners LLC 的持股数量始终未变。 最近一期申报(Q2 2026)显示持股 32,983 股、市值约 US$6.4M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2025 | 22.62K | $5.06M | 新进 |
| Q2 2026 | 32.98K | $6.43M | 新进 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RMD 与 13F 数据
RMD(RESMED INC)属于医疗保健行业。我们追踪的基金中还有 32 只申报持有 RMD。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 Parkman Healthcare Partners LLC
常见问题
How long has Parkman Healthcare Partners LLC held RMD?
Parkman Healthcare Partners LLC has disclosed RMD holdings in 2 of the last 6 reported quarters, going back to Q1 2025.
What is Parkman Healthcare Partners LLC's current position in RMD?
As of Q2 2026, Parkman Healthcare Partners LLC holds 32.98K shares of RMD (RESMED INC), valued at $6.43M, representing 0.66% of its reported portfolio and ranking #50.
Has Parkman Healthcare Partners LLC been buying or selling RMD?
In the latest 13F filing (Q2 2026), Parkman Healthcare Partners LLC newly opened its position in RMD. The position peaked in Q2 2026 at 32.98K shares.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.